NO962972L - Preparat for perkutan absorpsjon - Google Patents
Preparat for perkutan absorpsjonInfo
- Publication number
- NO962972L NO962972L NO962972A NO962972A NO962972L NO 962972 L NO962972 L NO 962972L NO 962972 A NO962972 A NO 962972A NO 962972 A NO962972 A NO 962972A NO 962972 L NO962972 L NO 962972L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- skin penetration
- percutaneous absorption
- percutaneously absorbable
- pgi2 derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28379394 | 1994-11-17 | ||
PCT/JP1995/002350 WO1996015793A1 (fr) | 1994-11-17 | 1995-11-16 | Preparation absorbable par voie percutanee |
Publications (2)
Publication Number | Publication Date |
---|---|
NO962972D0 NO962972D0 (no) | 1996-07-16 |
NO962972L true NO962972L (no) | 1996-09-16 |
Family
ID=17670220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO962972A NO962972L (no) | 1994-11-17 | 1996-07-16 | Preparat for perkutan absorpsjon |
Country Status (15)
Country | Link |
---|---|
US (1) | US5854281A (fr) |
EP (1) | EP0742011B1 (fr) |
JP (1) | JP4024852B2 (fr) |
KR (1) | KR100413202B1 (fr) |
CN (1) | CN1102850C (fr) |
AT (1) | ATE220911T1 (fr) |
AU (1) | AU713461B2 (fr) |
CA (1) | CA2181364A1 (fr) |
DE (1) | DE69527507T2 (fr) |
ES (1) | ES2180658T3 (fr) |
FI (1) | FI962869A (fr) |
NO (1) | NO962972L (fr) |
PT (1) | PT742011E (fr) |
TW (1) | TW413637B (fr) |
WO (1) | WO1996015793A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0925788A4 (fr) * | 1997-03-13 | 1999-12-01 | Toray Industries | Medicament pour traiter les lesions vasculaires diabetiques |
US6114337A (en) * | 1998-11-27 | 2000-09-05 | Pugliese; Peter T. | Zwitteronic-fatty acid compounds having anti-inflammatory properties |
US6448251B1 (en) * | 1997-11-28 | 2002-09-10 | Peter T. Pugliese | Zwitterionic-fatty acid compounds having anti-inflammatory properties |
ATE303774T1 (de) * | 1998-06-25 | 2005-09-15 | Lavipharm Lab Inc | Vorrichtung und verfahren zur behandlung von erektionsstörungen |
US7658938B2 (en) * | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
US20070148228A1 (en) * | 1999-02-22 | 2007-06-28 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
US8119159B2 (en) * | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
BR0015802B1 (pt) * | 1999-11-24 | 2014-04-29 | Agile Therapeutics Inc | Sistema de administração de contraceptivo transdérmico, e, método para produzir um sistema de administração de contraceptivo transdérmico |
JP2004528369A (ja) * | 2001-05-03 | 2004-09-16 | アラーガン、インコーポレイテッド | 向上した薬物動態特性を有する組成物 |
JP2004537516A (ja) * | 2001-05-11 | 2004-12-16 | オラセンス リミテッド | アンチセンス浸透促進剤 |
EP1627638B1 (fr) * | 2003-05-09 | 2017-07-12 | Toray Industries, Inc. | Béraprost et un inhibiteur du système rénine-angiotensine utilisés dans le traitement de maladies rénales |
AU2005204391A1 (en) * | 2004-01-14 | 2005-07-28 | Lavipharm Laboratories, Inc. | Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid |
US20090074844A1 (en) * | 2005-04-28 | 2009-03-19 | Ono Pharmaceutical Co., Ltd. | Trenadermal absorption preparation |
EP2007397B1 (fr) * | 2006-04-07 | 2013-07-24 | Merrion Research III Limited | Forme pharmaceutique solide par voie orale contenant un activateur |
WO2007146234A2 (fr) * | 2006-06-09 | 2007-12-21 | Merrion Research Ii Limited | Forme posologique solide à administrer par voie orale contenant un activateur |
TW200950799A (en) | 2008-05-07 | 2009-12-16 | Merrion Res Iii Ltd | Compositions of GnRH related compounds and processes of preparation |
US20130274352A1 (en) * | 2009-04-14 | 2013-10-17 | The Regents Of The University Of California | Oral Drug Devices and Drug Formulations |
US20110142889A1 (en) * | 2009-12-16 | 2011-06-16 | Nod Pharmaceuticals, Inc. | Compositions and methods for oral drug delivery |
AU2010339907A1 (en) | 2009-12-16 | 2012-07-05 | Nod Pharmaceuticals, Inc. | Compositions and methods for oral drug delivery |
WO2011120033A1 (fr) | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Compositions pharmaceutiques d'inhibiteurs de facteur xa sélectifs destinées à une administration orale |
CA2819234A1 (fr) | 2011-01-07 | 2012-07-12 | Merrion Research Iii Limited | Compositions pharmaceutiques de fer pour administration orale |
JP5878715B2 (ja) * | 2011-09-22 | 2016-03-08 | 久光製薬株式会社 | 貼付剤 |
JP6104230B2 (ja) * | 2012-03-22 | 2017-03-29 | 帝國製薬株式会社 | 経皮吸収型製剤 |
EP3031459B1 (fr) * | 2013-08-09 | 2019-01-09 | Teikoku Seiyaku Co., Ltd. | Pansement transdermique comprenant du béraprost |
WO2016120378A1 (fr) | 2015-01-29 | 2016-08-04 | Novo Nordisk A/S | Comprimés contenant un agoniste de glp-1 et revêtement gastro-résistant |
WO2018124281A1 (fr) * | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | Composition topique |
US20230391809A1 (en) * | 2022-06-07 | 2023-12-07 | Biomimetix Jv, Llc | Hydrophobic compositions including a hydrophilic active ingredient and methods relating thereto |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58124778A (ja) * | 1982-01-20 | 1983-07-25 | Toray Ind Inc | 5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体 |
ZA875317B (en) * | 1986-08-01 | 1988-01-25 | Warner-Lambert Company | Transdermal compositions |
EP0267617B1 (fr) * | 1986-11-14 | 1992-06-24 | Theratech, Inc. | Augmentation du pouvoir de pénétration au moyen d'un système binaire consistant en composées modifiant l'enveloppe cellulaire et en alcools à courte chaîne |
EP0375689B1 (fr) * | 1987-06-01 | 1992-08-12 | Warner-Lambert Company | Composition pharmaceutique adaptee a l administration transdermique d'un medicament opioid. |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
JP2503672B2 (ja) | 1989-07-28 | 1996-06-05 | 井関農機株式会社 | 草刈機の刈草収容装置 |
JPH0737389B2 (ja) * | 1989-08-29 | 1995-04-26 | 久光製薬株式会社 | プロスタグランジンe1含有の軟膏剤 |
JP2838297B2 (ja) * | 1989-11-02 | 1998-12-16 | 日産化学工業株式会社 | コルヒチン含有外用剤 |
JPH082801B2 (ja) * | 1989-11-09 | 1996-01-17 | 株式会社資生堂 | 経皮吸収促進剤及び皮膚外用剤 |
JP3243564B2 (ja) * | 1990-08-20 | 2002-01-07 | リードケミカル株式会社 | 外用貼付剤 |
JP3059204B2 (ja) * | 1990-10-25 | 2000-07-04 | 帝國製薬株式会社 | 安定なプロスタグランジンi▲下1▼類含有皮膚適用組成物 |
JPH04243827A (ja) * | 1991-01-25 | 1992-08-31 | Sumitomo Pharmaceut Co Ltd | プロスタグランジン誘導体含有溶解型軟膏剤 |
DE4124693A1 (de) * | 1991-07-22 | 1993-01-28 | Schering Ag | Carbacyclinderivate als mittel zur behandlung von vitiligo |
DE4124695C2 (de) * | 1991-07-22 | 1994-12-22 | Blitstein Willinger Eveline Dr | Verwendung von Carbacyclinderivaten zur Behandlung von Psoriasis vulgaris |
DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
US5403867A (en) * | 1992-02-07 | 1995-04-04 | Kaken Pharmaceutical Co., Ltd. | Preparation for treating wounds or hemorrhoids |
JP3102141B2 (ja) * | 1992-05-29 | 2000-10-23 | 東レ株式会社 | 養毛育毛剤 |
JP3115482B2 (ja) * | 1994-01-28 | 2000-12-04 | 帝人株式会社 | プロスタサイクリン類含有皮膚適用組成物 |
-
1995
- 1995-11-16 PT PT95938025T patent/PT742011E/pt unknown
- 1995-11-16 AU AU38811/95A patent/AU713461B2/en not_active Ceased
- 1995-11-16 US US08/676,250 patent/US5854281A/en not_active Expired - Fee Related
- 1995-11-16 KR KR1019960703834A patent/KR100413202B1/ko not_active IP Right Cessation
- 1995-11-16 CA CA002181364A patent/CA2181364A1/fr not_active Abandoned
- 1995-11-16 DE DE69527507T patent/DE69527507T2/de not_active Expired - Fee Related
- 1995-11-16 JP JP51673096A patent/JP4024852B2/ja not_active Expired - Fee Related
- 1995-11-16 CN CN95191250A patent/CN1102850C/zh not_active Expired - Fee Related
- 1995-11-16 EP EP95938025A patent/EP0742011B1/fr not_active Expired - Lifetime
- 1995-11-16 WO PCT/JP1995/002350 patent/WO1996015793A1/fr active IP Right Grant
- 1995-11-16 AT AT95938025T patent/ATE220911T1/de not_active IP Right Cessation
- 1995-11-16 ES ES95938025T patent/ES2180658T3/es not_active Expired - Lifetime
-
1996
- 1996-04-26 TW TW085105004A patent/TW413637B/zh not_active IP Right Cessation
- 1996-07-16 FI FI962869A patent/FI962869A/fi unknown
- 1996-07-16 NO NO962972A patent/NO962972L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996015793A1 (fr) | 1996-05-30 |
EP0742011A1 (fr) | 1996-11-13 |
KR100413202B1 (ko) | 2004-04-13 |
PT742011E (pt) | 2002-10-31 |
EP0742011B1 (fr) | 2002-07-24 |
AU713461B2 (en) | 1999-12-02 |
CN1102850C (zh) | 2003-03-12 |
CN1140412A (zh) | 1997-01-15 |
US5854281A (en) | 1998-12-29 |
FI962869A0 (fi) | 1996-07-16 |
FI962869A (fi) | 1996-09-16 |
AU3881195A (en) | 1996-06-17 |
DE69527507D1 (de) | 2002-08-29 |
ATE220911T1 (de) | 2002-08-15 |
EP0742011A4 (fr) | 1997-08-20 |
CA2181364A1 (fr) | 1996-05-30 |
DE69527507T2 (de) | 2002-11-07 |
TW413637B (en) | 2000-12-01 |
ES2180658T3 (es) | 2003-02-16 |
JP4024852B2 (ja) | 2007-12-19 |
NO962972D0 (no) | 1996-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO962972D0 (no) | Preparat for perkutan absorpsjon | |
US5326790A (en) | Administration of skin medications by use of dicarboxylic acids and derivatives | |
US5326566A (en) | Use of dibutyl adipate and isopropyl myristate in topical and transdermal products | |
IE940583L (en) | Topical antimicrobial pharmaceutical compositions | |
JPH085785B2 (ja) | 魚鱗癬の治療剤 | |
EE03377B1 (et) | Farmatseutilised liposoomsüstepreparaadid | |
CA2033725A1 (fr) | Compositions pharmaceutiques et cosmetiques | |
DK0582239T3 (da) | Farmaceutisk og/eller kosmetisk formulering | |
NO177774C (no) | Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel | |
IE810489L (en) | Composition for topical application | |
DK0416804T3 (da) | Præparat til udvortes administration | |
JP2002506805A (ja) | 保湿組成物 | |
IL96903A0 (en) | Topical pharmaceutical compositions comprising a vitamin d3 derivative | |
FR2616325B1 (fr) | Composition contenant de l'hydroquinone et de l'acide kojique et composition pharmaceutique, notamment dermatologique, a activite depigmentante ou anti-inflammatoire, ou cosmetique comprenant de l'acide kojique et de l'hydroquinone | |
EP0302836A1 (fr) | Compositions pharmaceutiques pour usage topique contenant de la miocamycine | |
JPH03120230A (ja) | 薬効成分の経皮吸収促進剤及び経皮吸収型製剤 | |
US5025026A (en) | Hair restorer | |
CA2111775A1 (fr) | Preparation pharmaceutique et/ou cosmetique | |
EP0685230A4 (fr) | Preparation dermatologique stable contenant de l'acide mycophenolique. | |
JPS61130207A (ja) | 養毛剤 | |
TH17795A (th) | ยา |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |